Your browser doesn't support javascript.
loading
DECC (dexamethasone, etoposide, chlorambucil, lomustine) as an oral chemotherapy regimen in relapsed and refractory diffuse large B-cell lymphoma.
Maddox, Jamie M; Horan, Matthew; Tafesh, Laith; Shrubsole, Caroline; Osborne, Wendy.
Afiliação
  • Maddox JM; Department of Haematology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
  • Horan M; Department of Haematology, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK.
  • Tafesh L; Department of Haematology, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK.
  • Shrubsole C; Department of Haematology, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK.
  • Osborne W; Department of Haematology, The Newcastle Upon Tyne NHS Foundation Trust, Newcastle, UK.
Br J Haematol ; 192(3): e92-e94, 2021 02.
Article em En | MEDLINE | ID: mdl-33336792
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Clorambucila / Linfoma Difuso de Grandes Células B / Etoposídeo / Lomustina Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Clorambucila / Linfoma Difuso de Grandes Células B / Etoposídeo / Lomustina Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article